Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo
$0.0002 0.00 (0.00%)
(As of 11/13/2024 ET)

About Nemaura Medical Stock (NASDAQ:NMRD)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.00
$0.03
52-Week Range
$0.00
$0.28
Volume
N/A
Average Volume
13,334 shs
Market Capitalization
$8,070.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

Nemaura Medical Inc (NMRD)
Elon Musk has put himself in their crosshairs
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
NXNN Nexeon Medsystems Inc
See More Headlines

NMRD Stock Analysis - Frequently Asked Questions

Nemaura Medical's stock was trading at $0.2190 at the start of the year. Since then, NMRD shares have decreased by 99.9% and is now trading at $0.0002.
View the best growth stocks for 2024 here
.

Nemaura Medical Inc. (NASDAQ:NMRD) released its quarterly earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter.

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Palantir Technologies (PLTR), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

Last Earnings
2/12/2024
Today
11/14/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$80,000.00
Book Value
($0.41) per share

Miscellaneous

Free Float
24,042,000
Market Cap
$8,070.00
Optionable
No Data
Beta
0.09
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:NMRD) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners